Tazemetostat is an investigational drug that kills cancer cells by stopping a gene called EZH2 from working. EZH2 affects how two other genes, INI1 and SMARCA4 work in cells. In early clinical development, tazemetostat has demonstrated clinical ...
Continue Reading...